BeStock  
Stocks › Biotechnology › EXEL

Exelixis EXEL

US equityMarket cap rank #1070Biotechnology
$64.63 −$1.20 (-1.82%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $64.63 0.00%
Open$65.95
Prev close$65.83
Day range$64.45 – $66.94
Volume2.19M
Market cap$15.77B
P/E (TTM)19.4
Dividend yield–

Analyst view

ConsensusBuy
Analysts7
Average target$65.00+0.6% vs. price
  • Buy 57%
  • Hold 29%
  • Sell 14%
Low $41.00Now $64.63Avg $65.00High $78.00

Recent rating changes

The last 20 actions on file set price targets from $41.00 to $78.00, averaging $55.93.

DateFirmRatingTarget
2 Nov 2026 H.C. Wainwright BUY $78.00
30 Oct 2026 TD Cowen BUY $76.00
19 Oct 2026 Citizens JMP BUY $65.00
9 Oct 2026 BofA Securities SELL $41.00
14 Sep 2026 Truist Financial HOLD –
11 Sep 2026 William Blair BUY –
11 Sep 2026 BofA Securities SELL $41.00
11 Sep 2026 Stifel HOLD –
6 Aug 2026 William Blair BUY –
5 Aug 2026 BofA Securities SELL $41.00
5 Aug 2026 Goldman Sachs BUY $64.00
3 Aug 2026 Truist Financial HOLD –
23 Jul 2026 Goldman Sachs BUY $64.00
7 Jul 2026 Truist Financial HOLD $56.00
2 Jul 2026 H.C. Wainwright BUY $56.00
25 Jun 2026 Truist Financial HOLD $54.00
22 Jun 2026 William Blair BUY –
22 Jun 2026 BofA Securities SELL $41.00
7 May 2026 H.C. Wainwright BUY $56.00
6 May 2026 Goldman Sachs BUY $50.00

Discussion

No comments yet — be the first to weigh in on EXEL.

Sign in to join the discussion.

Scroll to Top